WebbJiangsu XinChen-Techfields Pharma Co., LTD. lead institution Techfields Inc Techfields Pharma Co. Ltd Tianjin XinChen-Techfields Pharma Co., LTD. Active Ingredients Drugs … WebbOrganization Techfields Techfields Report issue For profit Phase 2 Phase 3 Founded: Suzhou China (2004) Status: No NME R&D (2004) Organization Overview First Clinical Trial 2014 NCT02067611 First Marketed Drug None First NDA Approval None Last Known Activity 2024 Timeline Acquisitions Trial Sponsor Other Trial Involvement 2000 2004

ibuprofenamine (X-0002) / Techfields - LARVOL DELTA

WebbIt is a non-steroidal anti-inflammatory drug (NSAID) which acts by targeting COX enzymes, COX-1 and COX-2. It is based on transdermal drug delivery technology. It was under development for pain of the lumbar spine, acute pain, gouty arthritis, rheumatoid arthritis (RA) and edema. WebbYou are viewing a free version of BCIQ, BioCentury's advanced business intelligence database for the biopharma industry. REQUEST A FREE TRIAL Overview Pipeline Deals … jessica anderson midwife

Klinisk prövning på Knäartros: X0002, Placebo - Kliniska ...

WebbQuality Scores of Fox Rothschild LLP based on the number of errors in issued patents. Time Period: Year ending 2024Q1. Number of Issued Patents: 380. Number of clients: 141. WebbTechfields Pharma Co Ltd View All. X-0002 overview. X-0002 (Ibuprofenamine) is under development for the treatment of osteoarthritis pain of knee, degenerative (neck and back) disease, prostatitis and fever. It is a small molecule. The drug candidate is administered by transdermal route. WebbTechfields Pharma is a clinical-stage pharmaceutical company focused on a completely new direction in the development of medicines for inflammatory diseases, autoimmune … jessica anderson heritage action